330 related articles for article (PubMed ID: 11499402)
41. Uptake of fluorescent plasmalogen analogs by cultured human skin fibroblasts deficient in plasmalogen.
Loidl J; Schwabe G; Paschke E; Paltauf F; Hermetter A
Biochim Biophys Acta; 1990 Nov; 1029(1):75-84. PubMed ID: 2223814
[TBL] [Abstract][Full Text] [Related]
42. Evidence against a major role of plasmalogens in the resistance of astrocytes in lactic acid-induced oxidative stress in vitro.
Fauconneau B; Stadelmann-Ingrand S; Favrelière S; Baudouin J; Renaud L; Piriou A; Tallineau C
Arch Toxicol; 2001 Jan; 74(11):695-701. PubMed ID: 11218046
[TBL] [Abstract][Full Text] [Related]
43. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
[TBL] [Abstract][Full Text] [Related]
44. Plasmalogens the neglected regulatory and scavenging lipid species.
Wallner S; Schmitz G
Chem Phys Lipids; 2011 Sep; 164(6):573-89. PubMed ID: 21723266
[TBL] [Abstract][Full Text] [Related]
45. Structural and functional roles of ether lipids.
Dean JM; Lodhi IJ
Protein Cell; 2018 Feb; 9(2):196-206. PubMed ID: 28523433
[TBL] [Abstract][Full Text] [Related]
46. Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic disease.
Paul S; Lancaster GI; Meikle PJ
Prog Lipid Res; 2019 Apr; 74():186-195. PubMed ID: 30974122
[TBL] [Abstract][Full Text] [Related]
47. Plasmalogen levels in Gaucher disease.
Moraitou M; Dimitriou E; Zafeiriou D; Reppa C; Marinakis T; Sarafidou J; Michelakakis H
Blood Cells Mol Dis; 2008; 41(2):196-9. PubMed ID: 18501647
[TBL] [Abstract][Full Text] [Related]
48. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport.
Munn NJ; Arnio E; Liu D; Zoeller RA; Liscum L
J Lipid Res; 2003 Jan; 44(1):182-92. PubMed ID: 12518037
[TBL] [Abstract][Full Text] [Related]
49. Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents.
Das AK; Holmes RD; Wilson GN; Hajra AK
Lipids; 1992 Jun; 27(6):401-5. PubMed ID: 1630273
[TBL] [Abstract][Full Text] [Related]
50. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells.
Mandel H; Sharf R; Berant M; Wanders RJ; Vreken P; Aviram M
Biochem Biophys Res Commun; 1998 Sep; 250(2):369-73. PubMed ID: 9753636
[TBL] [Abstract][Full Text] [Related]
51. Characterization of plasmalogen-selective phospholipase A2 from bovine brain.
Yang HC; Farooqui AA; Horrocks LA
Adv Exp Med Biol; 1996; 416():309-13. PubMed ID: 9131165
[TBL] [Abstract][Full Text] [Related]
52. Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation.
Ikuta A; Sakurai T; Nishimukai M; Takahashi Y; Nagasaka A; Hui SP; Hara H; Chiba H
Clin Chim Acta; 2019 Jun; 493():1-7. PubMed ID: 30796899
[TBL] [Abstract][Full Text] [Related]
53. [Glycolytic enzyme defects and neurodegeneration].
Hollán S; Vécsei L; Karg E; Németh I; Horanyi M; Inselt-Kovács M; Farkas T
C R Seances Soc Biol Fil; 1998; 192(5):929-45. PubMed ID: 9871806
[TBL] [Abstract][Full Text] [Related]
54. Normal plasmalogen levels are maintained in tissues from mice with hepatocyte-specific deletion in peroxin 5.
Werner ER; Swinkels D; Juric V; Dorninger F; Baes M; Keller MA; Berger J; Watschinger K
Brain Res Bull; 2023 Feb; 193():158-165. PubMed ID: 36584717
[TBL] [Abstract][Full Text] [Related]
55. The action of piracetam on the formation of ethanolamine-plasmalogen by neuronal microsomes of the developing rat brain.
Woelk H; Peiler-Ichikawa K
Arzneimittelforschung; 1978; 28(10):1752-6. PubMed ID: 582679
[TBL] [Abstract][Full Text] [Related]
56. HOCl-mediated glycerophosphocholine and glycerophosphoethanolamine generation from plasmalogens in phospholipid mixtures.
Lessig J; Fuchs B
Lipids; 2010 Jan; 45(1):37-51. PubMed ID: 19937395
[TBL] [Abstract][Full Text] [Related]
57. Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level.
Flasiński M; Hąc-Wydro K; Wydro P; Dynarowicz-Łątka P
J R Soc Interface; 2014 Jun; 11(95):20131103. PubMed ID: 24694892
[TBL] [Abstract][Full Text] [Related]
58. Lipid alterations following impact spinal cord injury in the rat.
Murphy EJ; Behrmann D; Bates CM; Horrocks LA
Mol Chem Neuropathol; 1994 Sep; 23(1):13-26. PubMed ID: 7893328
[TBL] [Abstract][Full Text] [Related]
59. Plasmalogens, docosahexaenoic acid and neurological disorders.
Farooqui AA; Ong WY; Horrocks LA
Adv Exp Med Biol; 2003; 544():335-54. PubMed ID: 14713251
[No Abstract] [Full Text] [Related]
60. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.
Brites P; Ferreira AS; da Silva TF; Sousa VF; Malheiro AR; Duran M; Waterham HR; Baes M; Wanders RJ
PLoS One; 2011; 6(12):e28539. PubMed ID: 22163031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
